GLP-1 SM 30mg Peptides
Precision meets discipline in a single, dependable vial engineered for serious research environments.
Better Molecule GLP-1 SM is a lyophilized peptide vial designed for controlled laboratory use, delivering a total content of 30mg. Presented as a stable, freeze-dried powder in a sealed glass vial, this format supports accurate handling, storage, and measured reconstitution according to internal lab protocols. The formulation is developed for researchers who prioritize consistency, traceability, and clean presentation.
- Each vial contains 30mg of GLP-1 SM, a glucagon-like peptide-1 analog frequently evaluated in studies of incretin signaling, appetite and satiety pathways, and glucose regulation models.
As a non-edible laboratory material, this lyophilized format is selected for its reliability during preparation and aliquoting. Researchers can reconstitute with an appropriate sterile diluent to achieve the desired working concentration, enabling repeatable dosing paradigms and streamlined method development. The solid-state matrix is optimized for stability during shipment and storage, supporting integrity across handling steps and minimizing variability between experiments.
Better Molecule emphasizes clarity and control at every stage. Vials are clearly labeled with lot and quantity for straightforward documentation. The packaging is designed for efficient bench workflows, helping minimize contamination risk during transfers and facilitating accurate record keeping. Whether you are building new models or refining established protocols, the clean presentation and measured strength of this vial support precise, reproducible work.
Quality and trust underpin the value of this material. GLP-1 SM is produced in the USA under stringent quality systems, with each lot undergoing analytical testing, including HPLC, to confirm identity and assess purity. Every batch is supported by a certificate of analysis and full lot traceability. Temperature-conscious handling, controlled packaging, and rigorous inspections reflect our commitment to consistency, transparency, and dependable performance in research settings.
For laboratory research use only. Not for human consumption, medical, veterinary, or household use. Handle using appropriate protective equipment and follow your institution’s safety and storage guidelines.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-1 SM?
GLP-1 SM appears to be a supplier-specific GLP-1-based research product. The 'SM' label is not a standardized pharmacologic name, so a careful description should avoid guessing the exact analog unless the sequence or active ingredient is shown on the specification sheet. It is best framed as a GLP-1-pathway research compound for laboratory use only.
What is GLP-1 SM typically studied for?
GLP-1-based compounds are generally studied for appetite regulation, glucose handling, insulin-related signaling, and body-weight change in metabolic models. For this specific item, the strongest FAQ wording is to explain the GLP-1 research category while also telling users to confirm the exact analog on the lot documents.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Better Molecule are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
